8 Articles
8 Articles
Pfizer reports adjusted earnings of $0.87 per share and raises 2026 revenue forecast to $62.0-64.0 billion
Pfizer reported a slight decrease in revenues in the third quarter, but improved forecasts for 2026, predicting an increase in revenues and profit per share. The company recorded a stability in operating revenues excluding Comirnaty and Paxlovid, with an increase of 7%.
Pfizer raises revenue projection to US$ 62 bi to US$ 64 bi and action-adjusted profit to US$ 2.95 to US$ 3.05 after balance above consensus
The pharmaceutical giant now expects annual revenue of $62 billion to $64 billion and adjusted earnings of $2.95 to $3.05 per share.
Coverage Details
Total News Sources8
Leaning Left0Leaning Right0Center1Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium








